Media Center

Discover the ground-breaking ECOnti project, where enGenes Biotech and partners have developed an integrated continuous manufacturing process that’s transforming biotechnology production. See how multiple industry partners have come together to create a seamless, continuous manufacturing system that enhances efficiency, reduces costs, and advances the future of biotechnology manufacturing. To watch the video, clink on this link: https://www.pharmaceutical-networking.com/econt

Vienna, Austria: – enGenes Biotech GmbH (enGenes) will share details of its progress towards the world’s first platform for truly continuous production of plasmid DNA (pDNA) with the bioscience community at the 44 th International Symposium on the Separation of Proteins, Peptides and Polynucleotides (ISPPP) in Munich. As part of the Continuous and Intensified Processing session, enGenes Senior Bioprocess Scientist Dr. Markus Berg will present “Continuous Downstream Process

Vienna, Austria: – enGenes Biotech GmbH (enGenes) will show its highly advanced bioprocessing solutions in protein expression and vaccine development at Europe’s flagship life sciences partnering conference, BIO-Europe 2025, this year in Vienna. The enGenes team will join other hi-tech biotech companies as part of a combined national presence at the Austrian Pavilion operated by LISAvienna, located at C32 GL in Hall C of the Messe Wien expo center. Enhanced yield expression T

When nucleic acid contamination in protein purification isn’t controlled, you face sticky lysates, slower chromatography, and reduced protein yield. Residual DNA also risks regulatory non-compliance. Learn how using endonucleases effectively can streamline processes, reduce unit economics, and make nuclease treatment a practical solution from early development to large-scale manufacturing. From uncovering how proteins work at the bench to developing therapeutic biologics or s

Vienna, Austria: – Bioprocessing solutions expert enGenes Biotech will share insights into its advanced vaccine development capabilities at the upcoming 2025 World Vaccine Congress in Amsterdam. The WVC franchise, with annual congresses in Europe and the USA, has become a leading global knowledge-sharing platform for the whole vaccine R&D and manufacturing value chain. enGenes will be an active participant in the many networking events in Amsterdam, detailing the various ways

Vienna, Austria: – Bioprocessing solutions expert enGenes Biotech is ready to unveil the first working prototype of a fully automated and integrated platform for true continuous production of recombinant proteins and plasmid DNA. The prototype will form the subject of a presentation by its Bioprocess Scientist Florian Simon, detailing the results of his PhD doctoral research resulting from enGenes’ engagement with the ECOnti program. Smart and stable platform Florian’s presen

Vienna, Austria: – Bioprocessing solutions expert enGenes Biotech has been invited to make its first-ever appearance at the Bioprocessing Network conference in Melbourne, Australia. enGenes CEO and co-founder, Dr. Jürgen Mairhofer will be one of the keynote speakers at the conference, presenting the company’s remarkable progress towards the first continuous and sustainable production of proteins in E. coli as part of the ECOnti Project. Continuous production prototype ECOnti,

Vienna, Austria: – Five months after attending the European BioProcess Summit in Barcelona, recombinant proteins and plasmid DNA specialist CDMO enGenes Biotech will also be a high-profile presence at the USA sister event, the 2025 Bioprocessing Summit in Boston. This is the first time enGenes has attended the linked summits on both sides of the Atlantic in a single year, partly reflecting its growing influence on bioprocessing science and technology with its patented express

Recombinant proteins and genetics specialist CDMO enGenes Biotech has embarked on a potentially transformational project to create a platform for continuous automated production of plasmid DNA (pDNA). The iCAP Project (Integrated Continuous and Automated Platform for Plasmid Production) is partly consequent from the success of the ECOnti collaboration for continuous protein production that united enGenes with development partners novasign® and Qubicon® AG to pioneer continuou

Within biotech, it's hard to think of an application that doesn’t involve proteins in some way or another. Whether it's research to identify and characterize proteins of interest, structural biology, development of a therapeutic protein or industrial fermentation, protein purification will be a key part of the workflow. Many approaches to protein purification exist and one step common to all is the need to eliminate host nucleic acids that are released during the process. W